+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Neuroprotection Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application

  • PDF Icon

    Report

  • 90 Pages
  • March 2024
  • Region: Global
  • Prof Research
  • ID: 5528666
Description Jump to:
This report describes the global market size of Neuroprotection from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029.

For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.

This report covers the following regions:

  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA
The key countries for each region are also included, such as the United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players of Neuroprotection as well as some smaller players.

The information for each competitor includes:

  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Applications Segment:

  • Prevention
  • Treatment

Companies Covered:

  • Daiichi Sankyo Company
  • Eli Lilly and Company
  • Allergan
  • Dr. Reddy’s Laboratories
  • Teva Pharmaceutical
  • Novartis
  • AstraZeneca
  • Astrocyte Pharmaceuticals
Base Year: 2024
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 COVID-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Neuroprotection Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Neuroprotection Market in North America (2019-2029)
8.1 Neuroprotection Market Size
8.2 Neuroprotection Market by End Use
8.3 Competition by Players/Suppliers
8.4 Neuroprotection Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Neuroprotection Market in South America (2019-2029)
9.1 Neuroprotection Market Size
9.2 Neuroprotection Market by End Use
9.3 Competition by Players/Suppliers
9.4 Neuroprotection Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Neuroprotection Market in Asia & Pacific (2019-2029)
10.1 Neuroprotection Market Size
10.2 Neuroprotection Market by End Use
10.3 Competition by Players/Suppliers
10.4 Neuroprotection Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Neuroprotection Market in Europe (2019-2029)
11.1 Neuroprotection Market Size
11.2 Neuroprotection Market by End Use
11.3 Competition by Players/Suppliers
11.4 Neuroprotection Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Neuroprotection Market in MEA (2019-2029)
12.1 Neuroprotection Market Size
12.2 Neuroprotection Market by End Use
12.3 Competition by Players/Suppliers
12.4 Neuroprotection Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Neuroprotection Market (2019-2024)
13.1 Neuroprotection Market Size
13.2 Neuroprotection Market by End Use
13.3 Competition by Players/Suppliers
13.4 Neuroprotection Market Size by Type
Chapter 14 Global Neuroprotection Market Forecast (2024-2029)
14.1 Neuroprotection Market Size Forecast
14.2 Neuroprotection Application Forecast
14.3 Competition by Players/Suppliers
14.4 Neuroprotection Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Daiichi Sankyo Company
15.1.1 Company Profile
15.1.2 Main Business and Neuroprotection Information
15.1.3 SWOT Analysis of Daiichi Sankyo Company
215.1.4 Daiichi Sankyo Company Neuroprotection Revenue, Gross Margin and Market Share (2019-2024)
15.2 Eli Lilly and Company
15.2.1 Company Profile
15.2.2 Main Business and Neuroprotection Information
15.2.3 SWOT Analysis of Eli Lilly and Company
215.2.4 Eli Lilly and Company Neuroprotection Revenue, Gross Margin and Market Share (2019-2024)
15.3 Allergan
15.3.1 Company Profile
15.3.2 Main Business and Neuroprotection Information
15.3.3 SWOT Analysis of Allergan
215.3.4 Allergan Neuroprotection Revenue, Gross Margin and Market Share (2019-2024)
15.4 Dr. Reddy’s Laboratories
15.4.1 Company Profile
15.4.2 Main Business and Neuroprotection Information
15.4.3 SWOT Analysis of Dr. Reddy’s Laboratories
215.4.4 Dr. Reddy’s Laboratories Neuroprotection Revenue, Gross Margin and Market Share (2019-2024)
15.5 Teva Pharmaceutical
15.5.1 Company Profile
15.5.2 Main Business and Neuroprotection Information
15.5.3 SWOT Analysis of Teva Pharmaceutical
215.5.4 Teva Pharmaceutical Neuroprotection Revenue, Gross Margin and Market Share (2019-2024)
15.6 Novartis
15.6.1 Company Profile
15.6.2 Main Business and Neuroprotection Information
15.6.3 SWOT Analysis of Novartis
215.6.4 Novartis Neuroprotection Revenue, Gross Margin and Market Share (2019-2024)
15.7 AstraZeneca
15.7.1 Company Profile
15.7.2 Main Business and Neuroprotection Information
15.7.3 SWOT Analysis of AstraZeneca
215.7.4 AstraZeneca Neuroprotection Revenue, Gross Margin and Market Share (2019-2024)
15.8 Astrocyte Pharmaceuticals
15.8.1 Company Profile
15.8.2 Main Business and Neuroprotection Information
15.8.3 SWOT Analysis of Astrocyte Pharmaceuticals
215.8.4 Astrocyte Pharmaceuticals Neuroprotection Revenue, Gross Margin and Market Share (2019-2024)
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Neuroprotection Report
Table Data Sources of Neuroprotection Report
Table Major Assumptions of Neuroprotection Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Neuroprotection Picture
Table Neuroprotection Classification
Table Neuroprotection Applications
Table Drivers of Neuroprotection Market
Table Restraints of Neuroprotection Market
Table Opportunities of Neuroprotection Market
Table Threats of Neuroprotection Market
Table COVID-19 Impact For Neuroprotection Market
Table Raw Materials Suppliers
Table Different Production Methods of Neuroprotection
Table Cost Structure Analysis of Neuroprotection
Table Key End Users
Table Latest News of Neuroprotection Market
Table Merger and Acquisition
Table Planned/Future Project of Neuroprotection Market
Table Policy of Neuroprotection Market
Table 2019-2029 North America Neuroprotection Market Size
Figure 2019-2029 North America Neuroprotection Market Size and CAGR
Table 2019-2029 North America Neuroprotection Market Size by Application
Table 2019-2024 North America Neuroprotection Key Players Revenue
Table 2019-2024 North America Neuroprotection Key Players Market Share
Table 2019-2029 North America Neuroprotection Market Size by Type
Table 2019-2029 United States Neuroprotection Market Size
Table 2019-2029 Canada Neuroprotection Market Size
Table 2019-2029 Mexico Neuroprotection Market Size
Table 2019-2029 South America Neuroprotection Market Size
Figure 2019-2029 South America Neuroprotection Market Size and CAGR
Table 2019-2029 South America Neuroprotection Market Size by Application
Table 2019-2024 South America Neuroprotection Key Players Revenue
Table 2019-2024 South America Neuroprotection Key Players Market Share
Table 2019-2029 South America Neuroprotection Market Size by Type
Table 2019-2029 Brazil Neuroprotection Market Size
Table 2019-2029 Argentina Neuroprotection Market Size
Table 2019-2029 Chile Neuroprotection Market Size
Table 2019-2029 Peru Neuroprotection Market Size
Table 2019-2029 Asia & Pacific Neuroprotection Market Size
Figure 2019-2029 Asia & Pacific Neuroprotection Market Size and CAGR
Table 2019-2029 Asia & Pacific Neuroprotection Market Size by Application
Table 2019-2024 Asia & Pacific Neuroprotection Key Players Revenue
Table 2019-2024 Asia & Pacific Neuroprotection Key Players Market Share
Table 2019-2029 Asia & Pacific Neuroprotection Market Size by Type
Table 2019-2029 China Neuroprotection Market Size
Table 2019-2029 India Neuroprotection Market Size
Table 2019-2029 Japan Neuroprotection Market Size
Table 2019-2029 South Korea Neuroprotection Market Size
Table 2019-2029 Southeast Asia Neuroprotection Market Size
Table 2019-2029 Australia Neuroprotection Market Size
Table 2019-2029 Europe Neuroprotection Market Size
Figure 2019-2029 Europe Neuroprotection Market Size and CAGR
Table 2019-2029 Europe Neuroprotection Market Size by Application
Table 2019-2024 Europe Neuroprotection Key Players Revenue
Table 2019-2024 Europe Neuroprotection Key Players Market Share
Table 2019-2029 Europe Neuroprotection Market Size by Type
Table 2019-2029 Germany Neuroprotection Market Size
Table 2019-2029 France Neuroprotection Market Size
Table 2019-2029 United Kingdom Neuroprotection Market Size
Table 2019-2029 Italy Neuroprotection Market Size
Table 2019-2029 Spain Neuroprotection Market Size
Table 2019-2029 Belgium Neuroprotection Market Size
Table 2019-2029 Netherlands Neuroprotection Market Size
Table 2019-2029 Austria Neuroprotection Market Size
Table 2019-2029 Poland Neuroprotection Market Size
Table 2019-2029 Russia Neuroprotection Market Size
Table 2019-2029 MEA Neuroprotection Market Size
Figure 2019-2029 MEA Neuroprotection Market Size and CAGR
Table 2019-2029 MEA Neuroprotection Market Size by Application
Table 2019-2024 MEA Neuroprotection Key Players Revenue
Table 2019-2024 MEA Neuroprotection Key Players Market Share
Table 2019-2029 MEA Neuroprotection Market Size by Type
Table 2019-2029 Egypt Neuroprotection Market Size
Table 2019-2029 Israel Neuroprotection Market Size
Table 2019-2029 South Africa Neuroprotection Market Size
Table 2019-2029 Gulf Cooperation Council Countries Neuroprotection Market Size
Table 2019-2029 Turkey Neuroprotection Market Size
Table 2019-2024 Global Neuroprotection Market Size by Region
Table 2019-2024 Global Neuroprotection Market Size Share by Region
Table 2019-2024 Global Neuroprotection Market Size by Application
Table 2019-2024 Global Neuroprotection Market Share by Application
Table 2019-2024 Global Neuroprotection Key Vendors Revenue
Figure 2019-2024 Global Neuroprotection Market Size and Growth Rate
Table 2019-2024 Global Neuroprotection Key Vendors Market Share
Table 2019-2024 Global Neuroprotection Market Size by Type
Table 2019-2024 Global Neuroprotection Market Share by Type
Table 2024-2029 Global Neuroprotection Market Size by Region
Table 2024-2029 Global Neuroprotection Market Size Share by Region
Table 2024-2029 Global Neuroprotection Market Size by Application
Table 2024-2029 Global Neuroprotection Market Share by Application
Table 2024-2029 Global Neuroprotection Key Vendors Revenue
Figure 2024-2029 Global Neuroprotection Market Size and Growth Rate
Table 2024-2029 Global Neuroprotection Key Vendors Market Share
Table 2024-2029 Global Neuroprotection Market Size by Type
Table 2024-2029 Neuroprotection Global Market Share by Type

Companies Mentioned

  • Daiichi Sankyo Company
  • Eli Lilly and Company
  • Allergan
  • Dr. Reddy’s Laboratories
  • Teva Pharmaceutical
  • Novartis
  • AstraZeneca
  • Astrocyte Pharmaceuticals
  • Roche
  • Biogen

Related Topics

Related Reports

Neuroprotection Market by Product, Treatment, Route of Administration, Application, End Users - Global Forecast 2025-2030 - Product Image

Neuroprotection Market by Product, Treatment, Route of Administration, Application, End Users - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Neuroprotection Therapeutics - Global Strategic Business Report - Product Image

Neuroprotection Therapeutics - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-Morbidity Factors Part B. International Review of Neurobiology Volume 172 - Product Image

Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-Morbidity Factors Part B. International Review of Neurobiology Volume 172

  • Book
  • Global
Mechanisms of Cell Death and Approaches to Neuroprotection/Disease Modification in Parkinson's Disease. International Review of Movement Disorders Volume 2 - Product Image

Mechanisms of Cell Death and Approaches to Neuroprotection/Disease Modification in Parkinson's Disease. International Review of Movement Disorders Volume 2

  • Book
  • Global
Hormones in Neurodegeneration, Neuroprotection, and Neurogenesis. Edition No. 1 - Product Image

Hormones in Neurodegeneration, Neuroprotection, and Neurogenesis. Edition No. 1

  • Book
  • 404 Pages
Copyright © 2002-2024 Research and Markets. All Rights Reserved.